92 related articles for article (PubMed ID: 9456242)
1. The detection of changes in mammographic densities.
Ursin G; Astrahan MA; Salane M; Parisky YR; Pearce JG; Daniels JR; Pike MC; Spicer DV
Cancer Epidemiol Biomarkers Prev; 1998 Jan; 7(1):43-7. PubMed ID: 9456242
[TBL] [Abstract][Full Text] [Related]
2. Reversal of gonadotropin-releasing hormone agonist induced reductions in mammographic densities on stopping treatment.
Gram IT; Ursin G; Spicer DV; Pike MC
Cancer Epidemiol Biomarkers Prev; 2001 Nov; 10(11):1117-20. PubMed ID: 11700258
[TBL] [Abstract][Full Text] [Related]
3. Changes in mammographic densities induced by a hormonal contraceptive designed to reduce breast cancer risk.
Spicer DV; Ursin G; Parisky YR; Pearce JG; Shoupe D; Pike A; Pike MC
J Natl Cancer Inst; 1994 Mar; 86(6):431-6. PubMed ID: 8120917
[TBL] [Abstract][Full Text] [Related]
4. Reduced mammographic density with use of a gonadotropin-releasing hormone agonist-based chemoprevention regimen in BRCA1 carriers.
Weitzel JN; Buys SS; Sherman WH; Daniels A; Ursin G; Daniels JR; MacDonald DJ; Blazer KR; Pike MC; Spicer DV
Clin Cancer Res; 2007 Jan; 13(2 Pt 1):654-8. PubMed ID: 17255289
[TBL] [Abstract][Full Text] [Related]
5. A randomized, placebo-controlled trial (NCIC CTG MAP1) examining the effects of letrozole on mammographic breast density and other end organs in postmenopausal women.
Cigler T; Tu D; Yaffe MJ; Findlay B; Verma S; Johnston D; Richardson H; Hu H; Qi S; Goss PE
Breast Cancer Res Treat; 2010 Apr; 120(2):427-35. PubMed ID: 19967558
[TBL] [Abstract][Full Text] [Related]
6. Sex steroids and breast cancer prevention.
Spicer DV; Pike MC
J Natl Cancer Inst Monogr; 1994; (16):139-47. PubMed ID: 7999456
[TBL] [Abstract][Full Text] [Related]
7. Hormonal reduction of mammographic densities: potential effects on breast cancer risk and performance of diagnostic and screening mammography.
Feig SA
J Natl Cancer Inst; 1994 Mar; 86(6):408-9. PubMed ID: 8120909
[No Abstract] [Full Text] [Related]
8. Assessment of mammographic density changes on plain film mammograms in postmenopausal women on hormone replacement therapy.
Orguc S; Goktan C; Ovali GY; Karaer O; Oruc S
Indian J Med Res; 2006 Nov; 124(5):545-52. PubMed ID: 17213523
[TBL] [Abstract][Full Text] [Related]
9. Screening mammography: value in women 35-39 years old.
Liberman L; Dershaw DD; Deutch BM; Thaler HT; Lippin BS
AJR Am J Roentgenol; 1993 Jul; 161(1):53-6. PubMed ID: 8517320
[TBL] [Abstract][Full Text] [Related]
10. Effects of hormone replacement therapy regimens on mammographic breast density: the role of progestins.
Topal NB; Ayhan S; Topal U; Bilgin T
J Obstet Gynaecol Res; 2006 Jun; 32(3):305-8. PubMed ID: 16764621
[TBL] [Abstract][Full Text] [Related]
11. Mammographic parenchymal patterns and quantitative evaluation of mammographic densities: a case-control study.
Wolfe JN; Saftlas AF; Salane M
AJR Am J Roentgenol; 1987 Jun; 148(6):1087-92. PubMed ID: 3495132
[TBL] [Abstract][Full Text] [Related]
12. Breast tissue density quantification via digitized mammograms.
Saha PK; Udupa JK; Conant EF; Chakraborty DP; Sullivan D
IEEE Trans Med Imaging; 2001 Aug; 20(8):792-803. PubMed ID: 11513030
[TBL] [Abstract][Full Text] [Related]
13. Mammographic appearance of cancer in the opposite breast: comparison with the first cancer.
Roubidoux MA; Lai NE; Paramagul C; Joynt LK; Helvie MA
AJR Am J Roentgenol; 1996 Jan; 166(1):29-31. PubMed ID: 8571898
[TBL] [Abstract][Full Text] [Related]
14. Tamoxifen and mammographic breast densities.
Brisson J; Brisson B; Coté G; Maunsell E; Bérubé S; Robert J
Cancer Epidemiol Biomarkers Prev; 2000 Sep; 9(9):911-5. PubMed ID: 11008908
[TBL] [Abstract][Full Text] [Related]
15. Investigation of lesions detected by mammography. The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. Canadian Association of Radiation Oncologists.
CMAJ; 1998 Feb; 158 Suppl 3():S9-14. PubMed ID: 9484273
[TBL] [Abstract][Full Text] [Related]
16. Effect of postmenopausal hormonal replacement therapy on mammographic density and parenchymal pattern.
Laya MB; Gallagher JC; Schreiman JS; Larson EB; Watson P; Weinstein L
Radiology; 1995 Aug; 196(2):433-7. PubMed ID: 7617857
[TBL] [Abstract][Full Text] [Related]
17. Pain and increased mammographic density in women receiving hormone replacement therapy: a prospective study.
McNicholas MM; Heneghan JP; Milner MH; Tunney T; Hourihane JB; MacErlaine DP
AJR Am J Roentgenol; 1994 Aug; 163(2):311-5. PubMed ID: 8037021
[TBL] [Abstract][Full Text] [Related]
18. Less mammographic density after nasal versus oral administration of postmenopausal hormone therapy.
van Dijck JA; Otten JD; Karssemeijer N; Kenemans P; Verbeek AL; van der Mooren MJ
Climacteric; 2011 Dec; 14(6):683-8. PubMed ID: 21942620
[TBL] [Abstract][Full Text] [Related]
19. The National Breast and Cervical Cancer Early Detection Program: report on the first 4 years of mammography provided to medically underserved women.
May DS; Lee NC; Nadel MR; Henson RM; Miller DS
AJR Am J Roentgenol; 1998 Jan; 170(1):97-104. PubMed ID: 9423608
[TBL] [Abstract][Full Text] [Related]
20. The Gothenburg breast screening trial: first results on mortality, incidence, and mode of detection for women ages 39-49 years at randomization.
Bjurstam N; Björneld L; Duffy SW; Smith TC; Cahlin E; Eriksson O; Hafström LO; Lingaas H; Mattsson J; Persson S; Rudenstam CM; Säve-Söderbergh J
Cancer; 1997 Dec; 80(11):2091-9. PubMed ID: 9392331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
